Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ 4Dzg r,V
'")'
h
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 4KxuSI^q
O{c#&/ .K
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© Zp[>[1@+
Lbrn8,G\
1.Co-stimulators (or co-stimulating molecules) &Hf%Va[B
Sx~mc_ekY
2.NK-kB +<@1)qZ(E
~eP~c"L
3.Immunoglobulin superfamily =os!^{p7>
E[ -yfP~[
4.antigen-presenting cell (APC) ZR=i*y
cr0/.Zv)
5.death domain 46
0/eW\
Rq2bj
_ j
6.CCR and CXCR !a V:T&6
>\'}&oi
7.Lectin (or mitogen) Lfa&JKd
+6+1N)L
8.Clusters of differentiation, CD) vnbY^ASdw
3zfiegY@wm
9.B7 family VFq\{@-
%
NODg_J~T
10.Cytotoxic T lymphocyte, CTL) 32j#kJ W
]{|
l4e4P
11.IL-15 and IL-15 receptor (IL-15R) oWDn_GnG`h
Pu!C,7vUQ
12.MHC restriction {=!BzNMj
%F-yFN"
13.Affinity-chromatography 0#Q]>V@rO4
D}ZPgt#
14.Cyctosprin A, CsA h{~GzrL*
d[;&2Jz*
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) +-V4:@
{~\:4
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© NDe FY
uE,TEa9;
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 TEK#AR
YD~(l-?"
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ /bC@^Y&}
L&5zr_
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ :Xx7':5
n:<Xp[;R
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Z#;\Rb.x7
8-O:e
ÃâÒßѧרҵ£º oO;<$wx2t
O]25{
L
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ --`W1!jI@
[#:yOZt
Ïû»¯ÄÚ¿Æ£º 4]cr1K
^
|;C;d"JC2
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ fL&e
^Q
lqoVfj'6M
ѪҺ²¡Ñ§×¨Òµ£º {]y!2r
_oU~S$hO
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿